Pillie – Medication Reminder
GRATUIT
Free
Screenshots
Description
The MiniMed Go™ system helps people manage diabetes. It is a single-app solution that can integrate glucose measurements captured from a compatible continuous glucose monitor (CGM) with data on insulin doses delivered by the InPen™ smart insulin pen.
The app can be used with InPen, Instinct or Simplera™ CGMs, as well as with the Apple Watch™ to display glucose values and to receive sensor glucose alerts. When connected to a CGM, e.g., the Instinct sensor, the app supports display of Sensor Glucose (SG) values and trend arrows.
When connected to the InPen smart insulin pen, the app supports automatic logging insulin doses administered by InPen, tracking of active insulin, and a dose calculator. The app also supports alerts or reminders for low glucose, high glucose, and insulin doses.
The MiniMed Go app should only be used with supported mobile devices and operating systems. In order to access the list of the supported mobile devices and operating systems, go to https://www.medtronicdiabetes.com/customer-support/app-support/device-compatibility.
IMPORTANT NOTE: The MiniMed Go app is intended for use with the InPen smart insulin pen and compatible continuous glucose monitoring (CGM) systems (Instinct or Simplera) and compatible rapid-acting insulins (NovoRapid, Fiasp, or Humalog) to aid in diabetes management through multiple daily injections.
Instinct sensor with InPen smart insulin pen is indicated for ages 7 and up, or for ages 2-6 years under the supervision of an adult caregiver. Simplera sensor with InPen smart insulin pen is approved for ages 18 years and older. Adequate sight and hearing, compatible mobile device and operating system, pairing and connectivity, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings are all required for proper functioning of the system.
Treatment decisions are to be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications).
Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For complete details, consult the appropriate system and component user guides at https://www.medtronicdiabetes.com/support/download-library/user-guides, taking care to select the correct country.
©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Apple, App Store, and Apple Watch are trademarks of Apple Inc., registered in the U.S. and other countries and regions. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license. Other trademarks and trade names are those of their respective owners.
The app can be used with InPen, Instinct or Simplera™ CGMs, as well as with the Apple Watch™ to display glucose values and to receive sensor glucose alerts. When connected to a CGM, e.g., the Instinct sensor, the app supports display of Sensor Glucose (SG) values and trend arrows.
When connected to the InPen smart insulin pen, the app supports automatic logging insulin doses administered by InPen, tracking of active insulin, and a dose calculator. The app also supports alerts or reminders for low glucose, high glucose, and insulin doses.
The MiniMed Go app should only be used with supported mobile devices and operating systems. In order to access the list of the supported mobile devices and operating systems, go to https://www.medtronicdiabetes.com/customer-support/app-support/device-compatibility.
IMPORTANT NOTE: The MiniMed Go app is intended for use with the InPen smart insulin pen and compatible continuous glucose monitoring (CGM) systems (Instinct or Simplera) and compatible rapid-acting insulins (NovoRapid, Fiasp, or Humalog) to aid in diabetes management through multiple daily injections.
Instinct sensor with InPen smart insulin pen is indicated for ages 7 and up, or for ages 2-6 years under the supervision of an adult caregiver. Simplera sensor with InPen smart insulin pen is approved for ages 18 years and older. Adequate sight and hearing, compatible mobile device and operating system, pairing and connectivity, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings are all required for proper functioning of the system.
Treatment decisions are to be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications).
Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For complete details, consult the appropriate system and component user guides at https://www.medtronicdiabetes.com/support/download-library/user-guides, taking care to select the correct country.
©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Apple, App Store, and Apple Watch are trademarks of Apple Inc., registered in the U.S. and other countries and regions. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license. Other trademarks and trade names are those of their respective owners.
